BUDGET IMPACT OF INTRODUCING CEFTAZIDIME-AVIBACTAM (CAZ-AVI) FOR COMPLICATED INTRA-ABDOMINAL INFECTION (CIAI), COMPLICATED URINARY TRACT INFECTIONS (CUTI), AND HOSPITAL ACQUIRED PNEUMONIA INCLUDING VENTILATOR-ASSOCIATED PNEUMONIA (HAPNAP) TO A HOSPITAL FO

KongnakornT, TE; Tichy, E; Merinopoulou, E; Berto, M; Di Virgilio, R; Charbonneau, C

VALUE IN HEALTH, 2017; 20 (9): A782